Nicla La Verde

3.0k total citations
64 papers, 868 citations indexed

About

Nicla La Verde is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nicla La Verde has authored 64 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 13 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nicla La Verde's work include Cancer Treatment and Pharmacology (13 papers), HER2/EGFR in Cancer Research (11 papers) and COVID-19 and healthcare impacts (11 papers). Nicla La Verde is often cited by papers focused on Cancer Treatment and Pharmacology (13 papers), HER2/EGFR in Cancer Research (11 papers) and COVID-19 and healthcare impacts (11 papers). Nicla La Verde collaborates with scholars based in Italy, United Kingdom and United States. Nicla La Verde's co-authors include Gabriella Farina, Marina Chiara Garassino, Valter Torri, Anna Moretti, Sheila Piva, Giorgio Gherardi, A. Scanni, Marcello Gambacorta, Laura Guarnaccia and Stefania Elena Navone and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Nicla La Verde

59 papers receiving 846 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicla La Verde Italy	16	514	212	171	127	85	64	868
Vito Amoroso Italy	18	711 1.4×	151 0.7×	255 1.5×	340 2.7×	123 1.4×	71	1.1k
Yeşim Eralp Türkiye	21	555 1.1×	186 0.9×	344 2.0×	279 2.2×	52 0.6×	94	1.3k
Yüksel Küçükzeybek Türkiye	20	728 1.4×	215 1.0×	225 1.3×	298 2.3×	31 0.4×	102	1.2k
Justin D. Floyd United States	11	475 0.9×	121 0.6×	72 0.4×	178 1.4×	25 0.3×	17	846
Tiziana Campa Italy	17	539 1.0×	496 2.3×	238 1.4×	142 1.1×	37 0.4×	26	1.4k
Marco Fornili Italy	18	471 0.9×	205 1.0×	160 0.9×	218 1.7×	25 0.3×	48	1.1k
Heinz Tüchler Austria	15	215 0.4×	138 0.7×	91 0.5×	165 1.3×	39 0.5×	38	868
Gary V. Burton United States	23	732 1.4×	209 1.0×	422 2.5×	339 2.7×	101 1.2×	68	1.5k
Marek Brzosko Poland	20	165 0.3×	192 0.9×	34 0.2×	109 0.9×	62 0.7×	124	1.6k

Countries citing papers authored by Nicla La Verde

Since Specialization

Citations

This map shows the geographic impact of Nicla La Verde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicla La Verde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicla La Verde more than expected).

Fields of papers citing papers by Nicla La Verde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicla La Verde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicla La Verde. The network helps show where Nicla La Verde may publish in the future.

Co-authorship network of co-authors of Nicla La Verde

This figure shows the co-authorship network connecting the top 25 collaborators of Nicla La Verde. A scholar is included among the top collaborators of Nicla La Verde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicla La Verde. Nicla La Verde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cattaneo, Dario, Anna Lisa Ridolfo, Davide Dalu, et al.. (2025). Management of polypharmacy and potential drug-drug interactions in people with HIV and cancer: insights from a 4-year multidisciplinary clinic experience. Expert Opinion on Drug Metabolism & Toxicology. 21(6). 729–736.

Leone, Alberto Giovanni, Stefania Bonadonna, Chiara Cassani, et al.. (2024). Implications of hormonal carcinogenesis for transgender and gender-diverse people undergoing gender-affirming hormone therapy: an up-to-date review. SHILAP Revista de lepidopterología. 3(1). e000330–e000330. 1 indexed citations

Ruggieri, Lorenzo, Anna Lisa Ridolfo, Sara Giordana Rimoldi, et al.. (2024). Ralstonia insidiosa Bacteremia in Patients with Solid Cancer Treated by Means of a Central Venous Catheter. SHILAP Revista de lepidopterología. 4(2). 157–163. 1 indexed citations

Ruggieri, Lorenzo, Ottavia Amato, Davide Dalu, et al.. (2024). Rising Concern About the Carcinogenetic Role of Micro-Nanoplastics. International Journal of Molecular Sciences. 26(1). 215–215. 1 indexed citations

Leone, Alberto Giovanni, Raffaella Casolino, Dario Trapani, et al.. (2023). Position paper of the Italian association of medical oncology on health disparities among transgender and gender-diverse people: the Assisi recommendations. EClinicalMedicine. 65. 102277–102277. 7 indexed citations

Zambelli, Alberto, Marina Elena Cazzaniga, Nicla La Verde, et al.. (2023). A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy. The Breast. 71. 113–121. 2 indexed citations

Cantini, Luca, Giulia Mentrasti, Nicla La Verde, et al.. (2021). 35P Lung cancer diagnosis and continuum of care: How did the COVID-19 outbreak impact? Data from an Italian multicenter study. Journal of Thoracic Oncology. 16(4). S713–S713. 1 indexed citations

Silvestris, Nicola, Massimo Di Maïo, Antonio Russo, et al.. (2021). COVID-19 infection in cancer patients: what has been the contribution of Associazione Italiana Oncologia Medica (AIOM) to oncological care since the beginning of the first pandemic wave?. ESMO Open. 6(2). 100100–100100. 4 indexed citations

Miglietta, Federica, Maria Silvia Cona, Maria Vittoria Dieci, Valentina Guarneri, & Nicla La Verde. (2020). An overview of immune checkpoint inhibitors in breast cancer. SHILAP Revista de lepidopterología. 1(6). 452–472. 5 indexed citations

10.

Cagnazzo, Celeste, Alessandro Costanzo, Stefania Gori, et al.. (2020). Patient associations and clinical oncology research: how much does a patient’s voice really matter?. Expert Review of Pharmacoeconomics & Outcomes Research. 21(3). 433–440. 2 indexed citations

11.

Zambelli, Alberto, Edda Simoncini, Monica Giordano, et al.. (2020). Prospective observational study on the impact of the 21-gene assay on treatment decisions and resources optimization in breast cancer patients in Lombardy: The BONDX study. The Breast. 52. 1–7. 8 indexed citations

12.

Verde, Nicla La, Elena Collovà, Livio Blasi, et al.. (2020). Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study. Clinical Breast Cancer. 21(5). e489–e496. 7 indexed citations

13.

Fedele, Palma, Antonella Ferro, Valeria Sanna, et al.. (2020). Exploring metastatic breast cancer treatment changes during COVID-19 pandemic. Journal of Chemotherapy. 33(4). 263–268. 7 indexed citations

14.

Navone, Stefania Elena, Laura Guarnaccia, Marco Locatelli, et al.. (2018). Significance and Prognostic Value of The Coagulation Profile in Patients with Glioblastoma: Implications for Personalized Therapy. World Neurosurgery. 121. e621–e629. 33 indexed citations

15.

Gherardi, Giorgio, Elena Biagioli, Valter Torri, et al.. (2017). The prognostic role of tumor size in early breast cancer in the era of molecular biology. PLoS ONE. 12(12). e0189127–e0189127. 24 indexed citations

16.

Garrone, Ornella, Filippo Montemurro, Chiara Saggia, et al.. (2016). Eribulin in pretreated metastatic breast cancer patients: results of the TROTTER trial—a multicenter retrospective study of eribulin in real life. SpringerPlus. 5(1). 59–59. 29 indexed citations

17.

Torri, Valter, et al.. (2014). Efficacy of biological agents in metastatic triple-negative breast cancer. Cancer Treatment Reviews. 40(5). 605–613. 39 indexed citations

18.

Gullo, Giuseppe, Daniela Bettio, Monica Zuradelli, et al.. (2013). Level of HER2/neu amplification in primary tumours and metastases in HER2-positive breast cancer and survival after trastuzumab therapy. The Breast. 22(2). 190–193. 8 indexed citations

19.

Verde, Nicla La, Elena Collovà, Sara Lonardi, et al.. (2013). Male breast cancer: Clinical features and multimodal treatment in a retrospective survey analysis at Italian centers. ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/). 3 indexed citations

20.

Verde, Nicla La, Elena Collovà, Sara Lonardi, et al.. (2013). Male Breast Cancer: Clinical Features and Multimodal Treatment in a Retrospective Survey Analysis at Italian Centers. Tumori Journal. 99(5). 596–600. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact